Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
weight loss
Biotech
Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial
Lilly is now headed toward regulators, angling to submit approval applications for the next-gen obesity asset by the end of 2025.
Gabrielle Masson
Aug 7, 2025 6:30am
Mice given a brain protein lost weight without getting nauseous
Jul 24, 2025 7:00am
Rivus weight loss drug shows MASH win, muscle-sparing potential
Jun 24, 2025 10:07am
MindRank reports 10% weight loss on oral GLP-1 drug in phase 2b
Jun 24, 2025 10:06am
Amgen's ph. 3 MariTide studies will ramp up dosing to quell nausea
Jun 24, 2025 9:59am
Scholar Rock's SMA drug helps Zepbound patients retain muscle
Jun 18, 2025 9:10am
